- Home
- MIST vs MSLE Comparison
MIST vs MSLE Comparison
Compare MIST & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.71
Company Overview
Basic Information| Metric | MIST | MSLE |
|---|---|---|
| Founded | 2003 | N/A |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 173.9M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MIST | MSLE |
|---|---|---|
| Price | $1.71 | $7.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 68.2K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $7.83 |
| 52 Week High | $3.06 | $13.39 |
Technical Indicators
Market Signals| Indicator | MIST | MSLE |
|---|---|---|
| Relative Strength Index (RSI) | 47.34 | 25.40 |
| Support Level | $1.60 | N/A |
| Resistance Level | $1.79 | $11.98 |
| Average True Range (ATR) | 0.08 | 0.93 |
| MACD | 0.02 | -0.53 |
| Stochastic Oscillator | 71.15 | 0.82 |
Price Performance
Historical Comparison MIST
MSLE
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).